![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, February 22, 2018 11:03:28 AM
You're comparison for stock price is weak as well. They too are a developing company just like we are. Just light years ahead on their plan. Like you and others say, there's more to a stock than price right. Or is that argument only fitting when it comes to our stock.
They have revenue now, unlike us. That revenue will most likely increase, as products come on line. What will happen to their price if their phase 3 trials they're awaiting results on are good. At least that have completed phase 3's. We have completed zero, and have one phase 2 awaiting results. How does that compare to what they have accomplished? what did they just announce phase 3 results from? GvHD. We will be starting a phase one in that soon. Ahhhh but we can manufacture cheaper. That's all that matters. Did you see their market cap? Over half a billion? Their stock moves when they accomplish things. Ours sits still as if nobody cares. Or maybe because they accomplish things at a snails pace. All comes round and round in circles like you say for one reason. I'll let you avoid that answer yet again.
Maybacks Adds Award Winning Show to Its Lineup Discusses Maybacks Opportunity • AHRO • Aug 22, 2024 11:30 AM
North Bay Resources Announces First Gold Concentrate at Mt. Vernon Gold Mine, Assays 12 oz/ton Gold, 17.5 oz/ton Platinum, and 8 oz./ton Silver, Sierra County, California • NBRI • Aug 22, 2024 10:28 AM
All Things Mobile Analytic, Inc. Reports Major Growth with Over $11 Million in Revenue • ATMH • Aug 22, 2024 7:19 AM
Unitronix Announces Strategic Entry into Cryptocurrency Space • UTRX • Aug 21, 2024 10:00 AM
Mawson Finland Provides Update on Exploration Activities at Rajapalot • MFL • Aug 21, 2024 9:06 AM
Avant Technologies to Implement Robust Cybersecurity Measures for AI-Driven Healthcare Solutions • AVAI • Aug 21, 2024 8:00 AM